收藏切换
The practice of Chinese Medicine Data Monitoring Committee in the "Phase Ⅳ clinical trial of Danhong injection for stable coronary atherosclerotic heart disease"
收藏切换
Yuanyuan LENG1, Ya'nan YU1, Chunti SHEN2, Haixia DANG3, Zhong WANG1, *, Jun LIU1, *
World Clinical Drug | 2025, 46(4) : 340 - 347
Less
收藏切换
World Clinical Drug | 2025, 46(4): 340-347
• Topic •
The practice of Chinese Medicine Data Monitoring Committee in the "Phase Ⅳ clinical trial of Danhong injection for stable coronary atherosclerotic heart disease"
Full
Yuanyuan LENG1, Ya'nan YU1, Chunti SHEN2, Haixia DANG3, Zhong WANG1, *, Jun LIU1, *
Affiliations
  • 1.China Academy of Chinese Medical Sciences, Institute of Basic Research in Clinical Medicine, Beijing 100700, China
  • 2.Menghe Medical School Inheritance Studio, Changzhou Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Changzhou, Changzhou 213003, Jiangsu Province, China
  • 3.Development Center of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
Published: 2025-04-10 doi: 10.13683/j.wph.2025.04.004
Outline
收藏切换

In recent years, with the continuous practice and exploration of data monitoring committee (DMC), it has become an integral part of large-scale, multi-center, high-risk clinical researches in the world. The development of DMC in China is still in its infancy, and the DMC system has not been widely promoted in most of the researches in China, including the field of traditional Chinese medicine. In October 2019, the first Chinese Medicine DMC (CMDMC) group standard "Technical Specifications for Chinese Medicine Clinical Research Data Monitoring" was officially released.The standard integrates and reflects the characteristics of traditional Chinese medicine research in different stages, and effectively improving and promoting the quality of traditional Chinese medicine clinical research. This paper will take"Phase Ⅳ clinical trial of Danhong injection for stable coronary atherosclerotic heart disease" as an example to present a complete CMDMC practice case, focusing on the purpose established by CMDMC in this study, the problems to be solved, the specific operation mode, key recommendations and decision-making mode, etc., and comprehensively explain the dynamic intervention and management of CMDMC in the whole process, full coverage and full tracking of clinical research. The aim is to provide a model reference for establishing a complete quality control and quality assurance system of traditional Chinese medicine clinical research and improving the quality of traditional Chinese medicine clinical research.

Chinese Medicine Data Monitoring committee  /  Danhong injection  /  angina pectoris  /  clinical trial  /  Chinese medicine
冷媛媛, 于亚南, 申春悌, 党海霞, 王忠, 刘骏. 中医药数据监查委员会在“丹红注射液治疗稳定性冠状动脉粥样硬化性心脏病Ⅳ期临床试验”的实践. 世界临床药物, 2025 , 46 (4) : 340 -347 . DOI: 10.13683/j.wph.2025.04.004
Yuanyuan LENG, Ya'nan YU, Chunti SHEN, Haixia DANG, Zhong WANG, Jun LIU. The practice of Chinese Medicine Data Monitoring Committee in the "Phase Ⅳ clinical trial of Danhong injection for stable coronary atherosclerotic heart disease"[J]. World Clinical Drug, 2025 , 46 (4) : 340 -347 . DOI: 10.13683/j.wph.2025.04.004
Year 2025 volume 46 Issue 4
63
11
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.04.004
  • Receive Date:2024-10-23
  • Online Date:2026-11-09
  • Published:2025-04-10
Article Data
Affiliations
History
  • Received:2024-10-23
Funding
Affiliations
    1.China Academy of Chinese Medical Sciences, Institute of Basic Research in Clinical Medicine, Beijing 100700, China
    2.Menghe Medical School Inheritance Studio, Changzhou Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Changzhou, Changzhou 213003, Jiangsu Province, China
    3.Development Center of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.04.004
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT